Dipyridamole Induced Ischemia and Biomarkers

University of Pecs

Status: Completed

Conditions: Ischemic Heart Disease; Ischemic Attack

Treatments: Diagnostic Test: myocardial perfusion scintigraphy

Study type: Observational

Funder types: Other

Identifiers

NCT03688815

PTE3950

Details and patient eligibility

About

Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.

Full description

The prospectively enrolled patients were followed up to 5 years. Adverse major events (MI, stroke, death) suffered during follow-up were retrospectively analysed.

Enrollment: 50 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: 1. written informed consent. 2. clinical diagnosis of ischemic heart disease (IHD) -

Exclusion Criteria: 1. refused written informed consent. 2. lost data during follow-up

Trial design

50 participants in 1 patient group

Patients with ischemic heart disease

Description:

Patients with ischemic heart disease scheduled for myocardial perfusion scintigraphy were enrolled. Biomarkers were analysed form periferal blood. Patients outcome data were followed up to 5 years.

Treatment:

Diagnostic Test: myocardial perfusion scintigraphy